Growth • Zimmer Biomet Holdings
ZBH
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
-0,8%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
3,8%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
-4,4%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
-4,1%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-1,6%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
-1,1%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!